Page last updated: 2024-10-26

e 4031 and Reperfusion Injury

e 4031 has been researched along with Reperfusion Injury in 1 studies

E 4031: class III anti-arrhythmia agent; structure given in UD

Reperfusion Injury: Adverse functional, metabolic, or structural changes in tissues that result from the restoration of blood flow to the tissue (REPERFUSION) following ISCHEMIA.

Research Excerpts

ExcerptRelevanceReference
"Reperfusion arrhythmias were evaluated after a 5 minute occlusion period of the left main coronary artery."5.29Actions and interactions of E-4031 and tedisamil on reperfusion-induced arrhythmias and QT interval in rat in vivo. ( Bril, A; Gout, B; Landais, L, 1993)
"Reperfusion arrhythmias were evaluated after a 5 minute occlusion period of the left main coronary artery."1.29Actions and interactions of E-4031 and tedisamil on reperfusion-induced arrhythmias and QT interval in rat in vivo. ( Bril, A; Gout, B; Landais, L, 1993)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bril, A1
Landais, L1
Gout, B1

Other Studies

1 other study available for e 4031 and Reperfusion Injury

ArticleYear
Actions and interactions of E-4031 and tedisamil on reperfusion-induced arrhythmias and QT interval in rat in vivo.
    Cardiovascular drugs and therapy, 1993, Volume: 7, Issue:2

    Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Blood Pressure; Bridged Bicyclo Compounds; Br

1993